As tau PET scans are increasingly used in clinical settings, and visual read remains the approved method for interpreting scan outcomes, it is crucial to determine the accuracy of these methods for detecting tau pathology associated with AD. The gene discussed is MAPT; the disease is Alzheimer disease.